| Dr Dana Jean Kim, MD | |
|
200 Forbes St, Suite 200, Annapolis, MD 21401-1538 | |
| (410) 263-6363 | |
| (410) 263-4086 |
| Full Name | Dr Dana Jean Kim |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 200 Forbes St, Annapolis, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548341233 | NPI | - | NPPES |
| M60604 | Other | MD | CONTROLLED DANGEROUS SUBS |
| BK9853498 | Other | MD | CONTROLLED SUBSTANCE REG |
| D64378 | Other | MD | PHYSICIAN LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | D64378 (Maryland) | Primary |
| Entity Name | Childrens Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912939703 PECOS PAC ID: 0244143170 Enrollment ID: O20031107000130 |
News Archive
Duke Health-led researchers have discovered new information about the signaling mechanism of cells that could one day help guide development of more specific drug therapies.
Colorectal cancer survivors who maintained a stable body weight but lost muscle and developed fatty deposits in their muscles faced a 40 percent higher risk of premature death than patients who avoided both health issues.
Combination therapy with the PD-L1 inhibitor atezolizumab and the VEGF inhibitor bevacizumab significantly improves overall survival and progression-free survival in patients with unresectable hepatocellular carcinoma compared to standard of care, showed results from a phase 3 study reported at the ESMO Asia 2019 Congress.
If Americans want a private health insurance system that does not base the price of individually sold policies on that individual's health status and that does not allow an insurer to refuse to sell a policy because of an individual's health issues, then they should accept a mandate that all Americans purchase at least a minimum package of health insurance (Uwe Reinhardt, 6/25).
› Verified 3 days ago
| Entity Name | Mnr Industries Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093130924 PECOS PAC ID: 7416908843 Enrollment ID: O20160119000098 |
News Archive
Duke Health-led researchers have discovered new information about the signaling mechanism of cells that could one day help guide development of more specific drug therapies.
Colorectal cancer survivors who maintained a stable body weight but lost muscle and developed fatty deposits in their muscles faced a 40 percent higher risk of premature death than patients who avoided both health issues.
Combination therapy with the PD-L1 inhibitor atezolizumab and the VEGF inhibitor bevacizumab significantly improves overall survival and progression-free survival in patients with unresectable hepatocellular carcinoma compared to standard of care, showed results from a phase 3 study reported at the ESMO Asia 2019 Congress.
If Americans want a private health insurance system that does not base the price of individually sold policies on that individual's health status and that does not allow an insurer to refuse to sell a policy because of an individual's health issues, then they should accept a mandate that all Americans purchase at least a minimum package of health insurance (Uwe Reinhardt, 6/25).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dana Jean Kim, MD 10211 Sherman Heights Pl, Columbia, MD 21044-5416 Ph: (443) 621-7096 | Dr Dana Jean Kim, MD 200 Forbes St, Suite 200, Annapolis, MD 21401-1538 Ph: (410) 263-6363 |
News Archive
Duke Health-led researchers have discovered new information about the signaling mechanism of cells that could one day help guide development of more specific drug therapies.
Colorectal cancer survivors who maintained a stable body weight but lost muscle and developed fatty deposits in their muscles faced a 40 percent higher risk of premature death than patients who avoided both health issues.
Combination therapy with the PD-L1 inhibitor atezolizumab and the VEGF inhibitor bevacizumab significantly improves overall survival and progression-free survival in patients with unresectable hepatocellular carcinoma compared to standard of care, showed results from a phase 3 study reported at the ESMO Asia 2019 Congress.
If Americans want a private health insurance system that does not base the price of individually sold policies on that individual's health status and that does not allow an insurer to refuse to sell a policy because of an individual's health issues, then they should accept a mandate that all Americans purchase at least a minimum package of health insurance (Uwe Reinhardt, 6/25).
› Verified 3 days ago
John W Mcgrath, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 200 Forbes St, Annapolis, MD 21401 Phone: 410-263-6363 Fax: 410-263-4086 | |
Dr. Jeffrey T Nold, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 2024 West St Ste 400, Annapolis, MD 21401 Phone: 410-224-7667 Fax: 410-573-4926 | |
Dr. Gail Sue-ann Rose-green, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: Pm Pediatrics Of Annapolis, Festival At Riva Shopping Center, 2301-a Forest Drive, Annapolis, MD 21401 Phone: 410-266-6767 Fax: 410-266-6761 | |
Petra Vaclavkova, MD, PHD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2001 Medical Parkway, Annapolis, MD 21401 Phone: 443-481-1000 | |
Dr. Salwa Elsamanoudi, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2629 Riva Rd, Suite 112, Annapolis, MD 21401 Phone: 410-266-1000 Fax: 410-573-4028 | |
Dr. Suzanne Rindfleisch, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 443-481-6962 Fax: 443-481-6954 | |
Dr. Zwena Mcleod-o'donnell, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 200 Forbes St Ste 200, Annapolis, MD 21401 Phone: 410-263-6363 Fax: 410-263-7551 |